Literature DB >> 20689483

Public health response to a multidrug-resistant tuberculosis outbreak among Guatemalans in Tennessee, 2007.

Roque Miramontes1, Lauren Lambert, Maryam B Haddad, Valerie Boaz, Stephen Hawkins, Margaret Zylstra, Rachel Allen, Sheliah Rivers, Brenda Ali, Sarah Stuart Chewning, Erin Holt, Jon Warkentin.   

Abstract

BACKGROUND: In June 2007, the Tennessee Department of Health notified the Centers for Disease Control and Prevention of four multidrug-resistant tuberculosis (MDR TB) cases in individuals of Guatemalan descent, and requested onsite epidemiologic assistance to investigate this outbreak.
METHODS: A case was defined as either culture-confirmed MDR TB with a drug-susceptibility pattern closely resembling that of the index case, or a clinical diagnosis of active TB disease and corroborated contact with a person with culture-confirmed MDR TB. Medical records were reviewed, and patients and their contacts were interviewed.
RESULTS: Five secondary TB cases were associated with the index case. Of 369 contacts of the index case, 189 (51%) were evaluated. Of those, 97 (51%) had positive tuberculin skin test (TST) results, 79 (81%) began therapy for latent TB infection (LTBI), and 38 (48%) completed LTBI therapy.
CONCLUSION: Despite consistent follow up by public health officials, a low proportion of patients diagnosed with LTBI completed therapy. Clinicians and public health practitioners who serve immigrant communities should be vigilant for MDR TB.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20689483     DOI: 10.1097/SMJ.0b013e3181eba488

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  6 in total

1.  Mortality among tuberculosis patients with acquired resistance to second-line antituberculosis drugs--United States, 1993-2008.

Authors:  Julia V Ershova; Ekaterina V Kurbatova; Patrick K Moonan; J Peter Cegielski
Journal:  Clin Infect Dis       Date:  2014-05-20       Impact factor: 9.079

2.  A tuberculosis outbreak fueled by cross-border travel and illicit substances: Nevada and Arizona.

Authors:  Kiren Mitruka; Haley Blake; Philip Ricks; Roque Miramontes; Sapna Bamrah; Carla Chee; Laurie Hickstein
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

Review 3.  Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis.

Authors:  N Sarita Shah; Courtney M Yuen; Moonseong Heo; Arielle W Tolman; Mercedes C Becerra
Journal:  Clin Infect Dis       Date:  2013-09-24       Impact factor: 9.079

4.  Transmission of multidrug-resistant tuberculosis in the USA: a cross-sectional study.

Authors:  Patrick K Moonan; Larry D Teeter; Katya Salcedo; Smita Ghosh; Shama D Ahuja; Jennifer Flood; Edward A Graviss
Journal:  Lancet Infect Dis       Date:  2013-06-05       Impact factor: 25.071

Review 5.  Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.

Authors:  Suzanne M Marks; Sundari R Mase; Sapna Bamrah Morris
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079

Review 6.  Tuberculosis outbreak investigations in the United States, 2002-2008.

Authors:  Kiren Mitruka; John E Oeltmann; Kashef Ijaz; Maryam B Haddad
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.